MetLife, Inc. (LON:0K0X)
United Kingdom · Delayed Price · Currency is GBP · Price in USD | Market Cap | 48.28B +24.9% |
| Revenue (ttm) | 62.19B +14.8% |
| Net Income | 3.75B +33.5% |
| EPS | 5.75 +43.2% |
| Shares Out | n/a |
| PE Ratio | 13.44 |
| Forward PE | 9.51 |
| Dividend | 1.78 (2.31%) |
| Ex-Dividend Date | Nov 3, 2026 |
| Volume | 453 |
| Open | 103.91 |
| Previous Close | 102.97 |
| Day's Range | 102.56 - 103.97 |
| 52-Week Range | 66.00 - 106.48 |
| Beta | 0.77 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About MetLife
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative s... [Read more]
Financial Performance
In 2025, MetLife's revenue was $77.08 billion, an increase of 8.59% compared to the previous year's $70.98 billion. Earnings were $3.17 billion, a decrease of -24.92%.
Financial numbers in USD Financial StatementsNews
MetLife price target raised to $111 from $108 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on MetLife (MET) to $111 from $108 and keeps an Outperform rating on the shares.
MetLife price target raised to $112 from $109 at Mizuho
Mizuho raised the firm’s price target on MetLife (MET) to $112 from $109 and keeps an Outperform rating on the shares.
MetLife price target raised to $115 from $110 at Piper Sandler
Piper Sandler analyst Paul Newsome raised the firm’s price target on MetLife (MET) to $115 from $110 and keeps an Overweight rating on the shares. The firm walks away from…
MetLife Seeing Volume Growth Across the Board, CEO Says
MetLife President and CEO Michel Khalaf discusses the company's third-quarter earnings and outlook. Speaking on "Bloomberg The Close," Khalaf says MetLife has limited exposure to AI investments.
MetLife Earnings Call Transcript: Q3 2026
Adjusted EPS excluding notable items reached a record $2.85, up 22% YoY, while adjusted ROE was 19.6%. Broad segment growth and strong capital generation supported shareholder returns; elevated VII boosted results, with Q4 VII assumed to normalize.
MetLife Earnings release: Q3 2026
MetLife released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
MetLife Slides: Q3 2026
MetLife has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 5, 2026.
MetLife Quarterly report: Q3 2026
MetLife has published its Q3 2026 quarterly earnings report on November 5, 2026.
MetLife reports Q3 adjusted EPS $2.78, consensus $2.77
Reports Q3 revenue $20.52B, consensus $19.97B. Comment from Michel Khalaf, President and Chief Executive Officer: “We delivered the highest quarterly adjusted earnings per share in MetLife’s (MET) his...
MetLife CFO John McCallion Provides Third Quarter 2026 Financial Update Video
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided ...
MetLife Announces 3Q 2026 Results
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced its third quarter 2026 results. Earnings Return Per Share on Equity (ROE) 3Q 2026 3Q 2026 Net Income $3.67 ROE 42.7% Ad...
MetLife CEO and CFO to Speak at the J.P. Morgan Financials Conference
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer...
MetLife price target raised to $114 from $110 at TD Cowen
TD Cowen analyst Andrew Kligerman raised the firm’s price target on MetLife (MET) to $114 from $110 and keeps a Buy rating on the shares. The firm updated targets in…
MetLife price target raised to $110 from $108 at JPMorgan
JPMorgan raised the firm’s price target on MetLife (MET) to $110 from $108 and keeps an Overweight rating on the shares. The firm adjusted targets in the life insurance group…
MetLife announces MetLife Pet Insurance integrated through ChatGPT plugin
MetLife (MET) announced that MetLife Pet Insurance has integrated its insurance portal through a ChatGPT plugin, “enabling pet parents who use ChatGPT to easily link to MetLife Pet’s personalized quot...
MetLife to Announce Third Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) will release its third quarter 2026 financial results on Wednesday, November 4, 2026, after the market closes. The earnings news release, financial...
MetLife price target lowered to $109 from $112 at Mizuho
Mizuho analyst Yaron Kinar lowered the firm’s price target on MetLife (MET) to $109 from $112 and keeps an Outperform rating on the shares. The firm adjusted targets in the…
MetLife price target raised to $111 from $97 at Barclays
Barclays raised the firm’s price target on MetLife (MET) to $111 from $97 and keeps an Overweight rating on the shares. The firm adjusted targets in the life insurance group…
MetLife Declares Fourth Quarter 2026 Common Stock Dividend
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a fourth quarter 2026 common stock dividend of $0.5925 per share. The dividend will be pay...
MetLife price target raised to $110 from $105 at UBS
UBS analyst Michael Ward raised the firm’s price target on MetLife (MET) to $110 from $105 and keeps a Buy rating on the shares. The life insurance sector faces a…
MetLife price target raised to $110 from $105 at TD Cowen
TD Cowen analyst Andrew Kligerman raised the firm’s price target on MetLife (MET) to $110 from $105 and keeps a Buy rating on the shares. The firm updated its model…
MetLife upgraded to Overweight from Neutral at Piper Sandler
Piper Sandler upgraded MetLife (MET) to Overweight from Neutral with a price target of $110, up from $99. The firm believes the market is not yet realizing MetLife’s strategic execution…
MetLife Investment Management closes Galaxy 38 CLO
MetLife (MET) Investment Management announced the close of Galaxy 38 CLO, a $450M target par new issue collateralized loan obligation. PineBridge Investments, which is part of MIM, serves as collatera...
MetLife Investment Management Closes Galaxy 38 CLO
WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd. (Galaxy...
MetLife Transcript: KBW Insurance Conference 2026
The New Frontier strategy is ahead of schedule, with strong EPS and ROE, disciplined expense management, and balanced growth across capital-light and capital-driven businesses. Group Benefits, RIS, and international markets are all delivering robust results, while asset management integration and capital returns remain key priorities.